Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study.
Michael NakhlaAmbica NairPrachi BalaniAditi UjjawalPramukh Arun KumarMahati DasariZeynep YukselenKannu BansalSarju GanatraSourbha S DaniPublished in: Cardiovascular drugs and therapy (2024)
GLP1-RAs exhibit higher reporting of suicide, hair loss, and aspiration events when compared to several other antidiabetic medications despite not meeting the criteria for positive signals yet. This warrants intensive monitoring and reporting.